NCT00205803View on ClinicalTrials.gov

Study Evaluating Pneumococcal Vaccine in Healthy Infants

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

249

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

May 31, 2007

Conditions
Healthy SubjectsPneumococcal Infections
Interventions
BIOLOGICAL

13-Valent Pneumococcal Conjugate Vaccine (13vPnC)

BIOLOGICAL

7-Valent Pneumococcal Conjugate Vaccine (7vPnC)

Trial Locations (1)

10045

New York

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00205803 - Study Evaluating Pneumococcal Vaccine in Healthy Infants | Biotech Hunter | Biotech Hunter